PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
03-Sep-2025 PLPC-DB: De-Risked Oncology Immunotherapy Asset With Global Licensing Window and STIP-NAM Framework ACCESS Newswire
03-Sep-2025 CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration ACCESS Newswire
03-Sep-2025 Zomedica Strengthens UK Market Position with Strategic Distribution Agreement for High-Growth Veterinary Innovation Portfolio ACCESS Newswire
03-Sep-2025 Ascelia Pharma Submits Orviglance New Drug Application to the U.S. Food and Drug Administration ACCESS Newswire
02-Sep-2025 Releaf Acquires Domain Releaf.com for £110,000 ACCESS Newswire
02-Sep-2025 Releaf Acquires Domain Releaf.com for £110,000 ACCESS Newswire
02-Sep-2025 Florence Announces AI-Assisted Workflows to Transform Clinical Trials ACCESS Newswire
02-Sep-2025 Fenja Capital II A/S Requests Conversion of All Outstanding Convertibles for a Total Nominal Amount of SEK 7.5 Million ACCESS Newswire
02-Sep-2025 Alligator Announces Evaluation and Option Agreement Covering RUBY(TM) Antibody Format ACCESS Newswire
02-Sep-2025 Medical Care Technologies Inc. (OTC PINK:MDCE) Unveils Patent-Pending AI Mental Health Tracker Targeting $400 Billion Market ACCESS Newswire
02-Sep-2025 NAYA Therapeutics to Partner With Atley Solutions to Accelerate Development & Commercialization of Its Astatine-211 Radio Pharmaceuticals ACCESS Newswire
02-Sep-2025 New World Medical Introduces the Ahmed ClearPath(R) ST Glaucoma Drainage Device ACCESS Newswire
02-Sep-2025 CASI Pharmaceuticals Appoints Barbara Krebs-Pohl, PhD to Board of Directors ACCESS Newswire
02-Sep-2025 MicroGenDX's New Testing Platform Cuts NGS Turnaround Time to 24 Hours for Life-Saving Decisions ACCESS Newswire
02-Sep-2025 IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada ACCESS Newswire
02-Sep-2025 VSee Health Teleradiology Expands to 25 Hospitals for an Estimated $3.0 Million Annualized Revenue ACCESS Newswire
02-Sep-2025 1933 Industries Announces Repurchase and Cancellation of Convertible Debentures ACCESS Newswire
02-Sep-2025 AlivaMab Biologics Announces Milestone- and Royalty-Free Access to AlivaMab(R) Mouse for Human Antibody Drug Discovery Services ACCESS Newswire
02-Sep-2025 Ablexis Announces Validation and Availability of AlivaMab(R) Mouse-NGX ACCESS Newswire
02-Sep-2025 Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism ACCESS Newswire